Edition:
United States

Clinigen Group PLC (CLINC.L)

CLINC.L on London Stock Exchange

736.50GBp
1 Dec 2016
Change (% chg)

-18.50p (-2.45%)
Prev Close
755.00p
Open
770.00p
Day's High
770.00p
Day's Low
730.50p
Volume
137,838
Avg. Vol
583,650
52-wk High
793.50p
52-wk Low
492.75p

CLINC.L

Chart for CLINC.L

About

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources... (more)

Overall

Beta: 0.76
Market Cap(Mil.): £853.42
Shares Outstanding(Mil.): 115.09
Dividend: 2.70
Yield (%): --

Financials

  CLINC.L Industry Sector
P/E (TTM): 63.04 42.21 29.87
EPS (TTM): 0.12 -- --
ROI: 4.88 -1.09 14.95
ROE: 6.12 -2.39 16.29

BRIEF-Clinigen group says CEO peter george to step down

* Shaun Chilton, current deputy CEO, will become CEO on that date Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Sep 28 2016

BRIEF-Clinigen Group reports FY reported revenue 339.9 mln stg

* Clinigen group plc: transformational year delivers 25% growth in adjusted EPS

Sep 28 2016

BRIEF-Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S

* Clinigen GrouE and Cumberland Pharmaceuticals launch Rthyol in U.S Source text for Eikon: Further company coverage:

Sep 26 2016

Earnings vs. Estimates